Company patents
INARI AGRICULTURE TECHNOLOGY, INC.
INARI AGRICULTURE TECHNOLOGY, INC. demonstrates a surprising focus beyond traditional agriculture, with a substantial 57.8% of its portfolio in pharma_biotech categories like Peptides & Proteins (26.8%) and Genetic & Microbiological Assays (25.8%), alongside its core New Plants / Plant Reproduction (32.0%). While patenting in New Plants / Plant Reproduction saw a significant 57.1% growth in 2025, the company's overall patenting activity appears to be shifting, with notable year-over-year declines so far in 2026 across its top three categories, including a -72.7% drop in New Plants / Plant Reproduction and -70.0% in Peptides & Proteins.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
97 US filings (since 2023) · 5 categories · 9 themes
Methods and compositions for introducing, modifying, or expressing foreign genetic material within plant cells to confer new traits, produce novel compounds, or enhance existing characteristics.
Utilization of specific DNA sequences (markers) to identify, select, or characterize plant varieties or traits, enabling more efficient breeding, quality control, and intellectual property protection.
Engineering or breeding plants to exhibit enhanced resistance or tolerance to pathogens (fungi, bacteria, viruses) or pests, often involving the identification and introduction of specific resistance genes or genomic regions.
Development and characterization of novel plant varieties or cultivars, including field crops, vegetables, fruits, and ornamental plants, focusing on improved agronomic performance, aesthetic qualities, or specific product characteristics.
Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.
Assays leveraging CRISPR-Cas systems (e.g., Cas12, Cas13) for highly specific and sensitive detection of target nucleic acids, often involving collateral cleavage activity or reporter molecules.
Computational techniques and algorithms for processing, aligning, and interpreting raw biological sequence data (DNA, RNA, protein), including identifying genetic variations, classifying organisms, or predicting sequence attributes.
Applying computational methods, often involving machine learning and multiomics data, to design, analyze, and understand biomolecules, genetic sequences, or complex biological systems.
Computational methods and systems for analyzing biological data (e.g., genomic, proteomic, clinical) to diagnose diseases, predict patient prognosis, assess treatment response, or stratify patients for therapy.
Patents
Showing 1-10 of 136